HIV News and Research

RSS

Combination of interventions more effective at reducing children’s symptoms of depression and anxiety

Behavioral scientists have long researched how to help children cope with extreme adversity – such as poverty or exposure to violence. Yanping Jiang, a researcher at the Rutgers Institute for Health, thinks she's found the answer in rural China.

9 Aug 2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

A clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the medications, but the rates of behavior change for alcohol consumption and smoking were high in all treatment groups. Results suggest these medications could play an important role to reduce alcohol use and smoking at the same time. Unexpectedly, nicotine replacement therapy performed as well as the prescription drugs varenicline and cytisine.

8 Aug 2022

What does the future look like for TB care?

In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.

5 Aug 2022

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

A team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection

3 Aug 2022

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

A study of COVID-19 variant transmission into and across Canada shows that international travel restrictions were a key intervention for reducing or slowing spread, according to a report published today in eLife.

2 Aug 2022

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

mRNA vaccines induce faster antibody response against infectious diseases

A new study describes that mRNA vaccines induce antigen-specific antibody response within a very short period of time after immunization.

2 Aug 2022

Symptoms of monkeypox differ from previous outbreaks

A new study describes the clinical characteristics of monkeypox infections during the current outbreak.

1 Aug 2022

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.

1 Aug 2022

How and when do de novo SARS-CoV-2 spike mutations emerge?

Researchers evaluated viral mutations in two patients with persistent SARS-CoV-2 infection.

1 Aug 2022

Special issue supports a national program to improve access to PrEP for preventing the spread of HIV

Researchers at the Johns Hopkins Bloomberg School of Public Health have contributed to a special issue of the Journal of Law, Medicine, and Ethics, including studies and commentary that support a national program to improve access to PrEP, a medication that prevents the spread of HIV.

29 Jul 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

A new research paper was published in Aging ("Aging (Albany NY)" by Medline/PubMed, "Aging-US" by Web of Science) Volume 14, Issue 13, entitled, "Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice."

29 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Researchers compared the potency of 17 human interferons (IFNs) against multiple SARS-CoV-2 variants.

27 Jul 2022

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Finding a cure for HIV has been extremely difficult, in part because the virus hides from antiretroviral treatments in one of the hardest places to reach: the brain.

27 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Scientists have described the prevalence of vaccine breakthrough SARS-CoV-2 infection in South Africa during the period of delta and omicron circulation.

27 Jul 2022

HIV News and Research

Combination of interventions more effective at reducing children’s symptoms of depression and anxiety

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

What does the future look like for TB care?

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

mRNA vaccines induce faster antibody response against infectious diseases

Symptoms of monkeypox differ from previous outbreaks

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

How and when do de novo SARS-CoV-2 spike mutations emerge?

Special issue supports a national program to improve access to PrEP for preventing the spread of HIV

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

Predicting viral antibody escape using pre-pandemic data

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Innovative technology reveals new insights into cellular reservoirs of HIV

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News